Rani Therapeutics Holdings, Inc. (RANI)

NGM – Real Time Price. Currency in USD

1.10

+0.03 (2.80%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-900K

-1M

-822K

-1M

Gross Profit

733K

-822K

-1M

Operating expenses (excl. COGS)

-39M

-50M

-65M

-62M

Operating Income

-38M

-50M

-66M

-63M

Non-operating income, total

-3M

-7M

-2M

177K

Pretax income

-41M

-57M

-68M

-63M

Equity in earnings

Taxes

-70K

Non-controlling/minority interest

11M

27M

34M

33M

After tax other income/expense

Net income before discontinued operations

-30M

-34M

-31M

Rani Therapeutics Holdings, Inc. (RANI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rani Therapeutics Holdings, Inc. (RANI)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Rani Therapeutics Holdings, Inc. (RANI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rani Therapeutics Holdings, Inc. (RANI)

Income Statement (Annual)

Income Statement (Annual)